Opportunity
Massachusetts COMMBUYS #BD-27-1031-ADMIN-ADM07-132007
Massachusetts Seeks Cepheid GeneXpert-Based HCV Point-of-Care Testing Solutions
Posted
August 04, 2026
Respond By
September 15, 2026
Identifier
BD-27-1031-ADMIN-ADM07-132007
NAICS
621511, 541690, 541715
This opportunity from the Massachusetts Department of Public Health seeks to expand hepatitis C virus (HCV) testing and treatment linkage in high-impact healthcare and social service settings. - Government Buyer: - Massachusetts Department of Public Health (DPH) - OEMs and Vendors: - Cepheid (GeneXpert system required) - Products/Services Requested: - Cepheid GeneXpert point-of-care diagnostic system for HCV testing - Development assistance services for implementing HCV testing and linkage to care - Two awards, each approximately $35,000 - Unique/Notable Requirements: - Use of Cepheid GeneXpert system is mandatory - Focus on broadening geographic and setting representation for HCV testing - Targeted at agencies able to implement point-of-care diagnostic strategies - Includes both technology and programmatic support for HCV elimination
Description
This solicitation seeks to advance the elimination of Hepatitis C infection through the use of point-of-care diagnostic strategies. The project supports enhancement and expansion of hepatitis C virus (HCV) testing and linkage to curative treatment in high impact health care and social service settings. The procurement involves the use of a point-of-care test system, specifically the Cepheid GeneXpert system. The award support is approximately $70,660 to support 2 awards, approximately $35,000 per agency. The procurement is managed by the Massachusetts Department of Public Health.